&l;p&g;&l;img class=&q;dam-image bloomberg size-large wp-image-42543595&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/42543595/960×0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; People take photographs of the Marina Bay Sands hotel and casino, center, and Singapore flyer illuminated at night in Singapore, on Wednesday, June 13, 2018. Photographer: SeongJoon Cho/Bloomberg
Bond yields rise for a number of reasons but tend to reflect an outlook for higher inflation and economic growth. One of the most popular benchmarks, the yield on the 10-year U.S. Treasury note, is back above the key psychological level of 3%. A little more than two years ago, the 10-year Treasury yield had plummeted below 1.35% after voters in the United Kingdom approved the exit of the U.K. from the European Union. The brexit vote shocked markets and sapped risk appetite but the low point in yield may have marked a generational turn in interest rates, which had been in decline since 1981 and especially over the past two decades.
Top 10 Casino Stocks To Buy For 2019: Mimecast Limited(MIME)
Advisors’ Opinion:
- [By Todd Campbell and Timothy Green]
Buying and holding shares in great companies like eBay for the long haul has proven to be very profit-friendly, but identifying growth stocks early on isn’t easy. To help find tomorrow’s winners, we asked two Motley Fool investors which burgeoning growth stocks are on their radar right now. They responded with Skechers (NYSE:SKX) and Mimecast (NASDAQ:MIME). Read on to find out if these stocks deserve a spot in your portfolio.
- [By Garrett Baldwin]
Eight Seconds… $1,260 Richer: Words can’t describe what you’ll see in this shocking footage – because you’ll witness, live on camera, one man become $4,238 richer with just three clicks of a mouse. And if you follow the simple instructions in this video, you’ll learn how to set yourself up for an instant $2,918 payday opportunity. You need to see this to believe it…
Three Stocks to Watch Today: COP, HD, HSBC
ConocoPhillips (NYSE: COP) has seized assets from the Venezuelan-owned firm PDVSA in the Caribbean. The company won a court case that will allow it to take over assets owned by the Venezuelan government. The court enabled the seizures as part of a broader plan to allow the firm to recoup roughly $2 billion following the 2007 nationalization of its assets in Venezuela by the huge Castro-led government.
Monday will be a quiet day on the earnings front. Investors are looking to Tuesday’s calendar, when The Home Depot Inc. (NYSE: HD) reports earnings. Tomorrow, Wall Street analysts expect that Home Depot will report earnings per share of $2.07 on top of $25.2 billion in revenue. Investors will be hoping that the company reports strong profits thanks to an improving U.S. economy and the recent tax reform law.
Expect a lot of chatter today about blockchain technology. That’s because ING Bank and HSBC Holdings Plc. (NYSE: HSBC) announced over the weekend that they engaged in their first trade ever using blockchain technology. The two engaged in a trade on behalf of Cargill to finance a shipment of soybeans from Argentina to Malaysia.
Today, look for earnings reports from Agilent Technologies (NYSE: A), Itron Inc. (Nasdaq: ITRI), Vipshop Holdings Ltd. (Nasdaq: VIPS), Amyris Biotechnologies Inc. (Nasdaq: AMRS), Sky Solar Holdings Ltd. (Nasdaq: SKYS), Mazor Robotics Ltd. (Nasdaq: MZOR), China Lodging Group Ltd. (Nasdaq: HTHT), and Mimecast Ltd. (Nasdaq: MIME).Follow Money Morning on Facebook, Twitter, and LinkedIn.
- [By Lisa Levin] Gainers
Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results.
LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat.
MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900.
SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results.
Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday.
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat.
Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday.
Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday.
PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results.
Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday.
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy.
Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat.
Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o - [By Ethan Ryder]
Get a free copy of the Zacks research report on Mimecast (MIME)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Mimecast (MIME)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Daniel Sparks]
Shares of Mimecast (NASDAQ:MIME) popped on Tuesday, rising as much as 20.6%. As of 1:15 p.m. EST today, the stock was up 13.2%.
Shares of the email and data security company were up because of the company’s fiscal third-quarter earnings release, which featured better-than-expected revenue and adjusted earnings per share.
Top 10 Casino Stocks To Buy For 2019: Physicians Realty Trust(DOC)
Advisors’ Opinion:
- [By Chris Neiger, Danny Vena, and Jordan Wathen]
To help investors find great companies to invest in — that are also top dividend stocks — we asked three Motley Fool investors for a list of such companies and they came back with Physicians Realty Trust (NYSE:DOC), Oaktree Capital Group (NYSE:OAK), and Enbridge (NYSE:ENB).
- [By Lee Jackson]
Physicians Realty Trust (NYSE: DOC) investors receive a 6.05% yield. Shares traded at $15.15 early Thursday. The 52-week range is $14.31 to $21.85, and the posted consensus price objective is $17.59.
- [By Tyler Crowe, Matthew Frankel, CFP, and Neha Chamaria]
So we asked three Motley Fool contributors to tell us about one of their favorite mid-cap stocks out there today. Here’s why they picked real estate investment trust (REIT) Physicians Realty Trust (NYSE:DOC), precious metal streaming company Royal Gold (NASDAQ:RGLD), and solar power component supplier SolarEdge Technologies (NASDAQ:SEDG).
Top 10 Casino Stocks To Buy For 2019: GlycoMimetics, Inc.(GLYC)
Advisors’ Opinion:
- [By Motley Fool Transcribers]
GlycoMimetics Inc (NASDAQ:GLYC)Q4 2018 Earnings Conference CallMarch 06, 2019, 8:30 a.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
- [By Logan Wallace]
Allianz Asset Management GmbH purchased a new stake in GlycoMimetics Inc (NASDAQ:GLYC) during the 1st quarter, Holdings Channel reports. The firm purchased 73,433 shares of the biotechnology company’s stock, valued at approximately $1,192,000.
- [By Stephan Byrd]
GlycoMimetics (NASDAQ:GLYC) was upgraded by investment analysts at BidaskClub from a “hold” rating to a “buy” rating in a research report issued on Wednesday.
- [By Motley Fool Transcribing]
GlycoMimetics (NASDAQ:GLYC) Q2 2018 Earnings Conference CallAug. 10, 2018 8:30 a.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
- [By Joseph Griffin]
GlycoMimetics (NASDAQ:GLYC)‘s stock had its “buy” rating reiterated by equities research analysts at Stifel Nicolaus in a research report issued to clients and investors on Sunday. They presently have a $24.00 price target on the biotechnology company’s stock. Stifel Nicolaus’ target price would suggest a potential upside of 64.16% from the company’s previous close.
- [By Max Byerly]
BidaskClub downgraded shares of GlycoMimetics (NASDAQ:GLYC) from a sell rating to a strong sell rating in a research report sent to investors on Saturday morning.
Top 10 Casino Stocks To Buy For 2019: On Assignment Inc.(ASGN)
Advisors’ Opinion:
- [By Max Byerly]
Get a free copy of the Zacks research report on ASGN (ASGN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Motley Fool Transcribing]
On Assignment (NYSE:ASGN) Q4 2018 Earnings Conference CallFeb. 13, 2019 5:00 p.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
- [By Joseph Griffin]
ASGN (NYSE: ASGN) and Amn Healthcare Services (NYSE:AMN) are both mid-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, dividends, profitability, risk, earnings, analyst recommendations and institutional ownership.
- [By Logan Wallace]
Insperity (NYSE: NSP) and ASGN (NYSE:ASGN) are both mid-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, dividends and valuation.
Top 10 Casino Stocks To Buy For 2019: Stantec Inc(STN)
Advisors’ Opinion:
- [By Stephan Byrd]
Steneum Coin (CURRENCY:STN) traded down 13% against the US dollar during the one day period ending at 21:00 PM Eastern on September 16th. During the last week, Steneum Coin has traded 36.4% lower against the US dollar. Steneum Coin has a market cap of $60,064.00 and $2,445.00 worth of Steneum Coin was traded on exchanges in the last 24 hours. One Steneum Coin coin can currently be purchased for approximately $0.0205 or 0.00000315 BTC on exchanges including Cryptopia, BTC-Alpha and CoinExchange.
- [By Ethan Ryder]
TRADEMARK VIOLATION NOTICE: “Scotia Capital Inc. Sells 15,249 Shares of Stantec Inc. (STN)” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece on another site, it was illegally stolen and reposted in violation of international copyright and trademark law. The legal version of this piece can be viewed at www.tickerreport.com/banking-finance/4192654/scotia-capital-inc-sells-15249-shares-of-stantec-inc-stn.html.
- [By Shane Hupp]
Get a free copy of the Zacks research report on Stantec (STN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Stantec (STN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 10 Casino Stocks To Buy For 2019: Exterran Corporation(EXTN)
Advisors’ Opinion:
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Exterran (EXTN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Robotti Robert lowered its holdings in Exterran Corp (NYSE:EXTN) by 0.7% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 365,072 shares of the energy company’s stock after selling 2,670 shares during the quarter. Exterran accounts for about 2.4% of Robotti Robert’s investment portfolio, making the stock its 13th largest position. Robotti Robert’s holdings in Exterran were worth $9,141,000 at the end of the most recent quarter.
- [By Stephan Byrd]
United Rentals (NYSE: URI) and Exterran (NYSE:EXTN) are both construction companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.
- [By Max Byerly]
Get a free copy of the Zacks research report on Exterran (EXTN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Shane Hupp]
Get a free copy of the Zacks research report on Exterran (EXTN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 10 Casino Stocks To Buy For 2019: Pinnacle Financial Partners, Inc.(PNFP)
Advisors’ Opinion:
- [By Max Byerly]
Pinnacle Financial Partners (NASDAQ:PNFP) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.
Pinnacle Entertainment (NASDAQ:PNK) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.
- [By Joseph Griffin]
Pinnacle Financial Partners (NASDAQ:PNFP) has been given a consensus recommendation of “Buy” by the fourteen research firms that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and eleven have assigned a buy recommendation to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $76.25.
- [By Max Byerly]
These are some of the news stories that may have impacted Accern’s scoring:
Get Pinnacle Financial Partners alerts:
Equities Analysts Set Expectations for Pinnacle Financial Partners’ Q2 2018 Earnings (PNFP) (americanbankingnews.com) Analysts Expect Pinnacle Financial Partners (PNFP) Will Post Quarterly Sales of $229.21 Million (americanbankingnews.com) Pinnacle Financial Partners’ (PNFP) Outperform Rating Reiterated at Hovde Group (americanbankingnews.com) Pinnacle Financial Partners (PNFP) Receives Average Rating of “Buy” from Brokerages (americanbankingnews.com) Zacks: Analysts Expect Pinnacle Financial Partners (PNFP) to Post $1.15 Earnings Per Share (americanbankingnews.com)
Several brokerages have recently weighed in on PNFP. Keefe, Bruyette & Woods raised shares of Pinnacle Financial Partners from a “market perform” rating to an “outperform” rating in a report on Friday, February 16th. Zacks Investment Research downgraded shares of Pinnacle Financial Partners from a “buy” rating to a “hold” rating in a report on Thursday, April 5th. Raymond James raised shares of Pinnacle Financial Partners from a “market perform” rating to an “outperform” rating in a report on Tuesday, April 10th. UBS Group raised shares of Pinnacle Financial Partners from a “market perform” rating to an “outperform” rating in a report on Tuesday, April 10th. Finally, Hovde Group reaffirmed an “outperform” rating and issued a $75.00 target price (up previously from $72.00) on shares of Pinnacle Financial Partners in a report on Friday. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $72.56.
- [By Max Byerly]
Pinnacle Financial Partners (NASDAQ:PNFP) Vice Chairman Ronald L. Samuel sold 1,600 shares of the stock in a transaction dated Tuesday, September 25th. The stock was sold at an average price of $63.49, for a total transaction of $101,584.00. Following the sale, the insider now owns 27,975 shares of the company’s stock, valued at approximately $1,776,132.75. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
- [By Ethan Ryder]
Penn Capital Management Co. Inc. raised its holdings in shares of Pinnacle Financial Partners (NASDAQ:PNFP) by 22.6% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 41,475 shares of the financial services provider’s stock after purchasing an additional 7,651 shares during the quarter. Penn Capital Management Co. Inc. owned 0.05% of Pinnacle Financial Partners worth $2,768,000 at the end of the most recent quarter.
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Pinnacle Financial Partners (PNFP)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 10 Casino Stocks To Buy For 2019: CSI Compressco LP(CCLP)
Advisors’ Opinion:
- [By Joseph Griffin]
These are some of the media headlines that may have effected Accern Sentiment’s rankings:
Get CSI Compressco alerts:
Stock to Follow:: CSI Compressco LP (CCLP),Superior Drilling Products, Inc. (SDPI) (bitcoinpriceupdate.review) Mammoth Energy Services (TUSK) & CSI Compressco (CCLP) Financial Analysis (americanbankingnews.com) Investor Watch: Quant Signal Review on CSI Compressco LP (NasdaqGS:CCLP) as ROE Touches -0.491870 (dunlappost.com) Quant Rating Update on CSI Compressco LP (NasdaqGS:CCLP) (dunlappost.com) Traders shouldn’t Staggering on these:: VAALCO Energy, Inc. (NYSE:EGY), CSI Compressco LP (NASDAQ:CCLP … (journalfinance.net)
CCLP has been the topic of a number of research analyst reports. Raymond James set a $8.00 price target on CSI Compressco and gave the stock a “buy” rating in a report on Tuesday, May 8th. BidaskClub upgraded CSI Compressco from a “hold” rating to a “buy” rating in a report on Saturday, April 14th. Stifel Nicolaus restated a “hold” rating and set a $7.00 price target (down from $8.00) on shares of CSI Compressco in a report on Tuesday, May 8th. Finally, ValuEngine upgraded CSI Compressco from a “sell” rating to a “hold” rating in a report on Friday, June 1st. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $6.50.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on CSI Compressco (CCLP)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Shane Hupp]
ValuEngine lowered shares of CSI Compressco (NASDAQ:CCLP) from a buy rating to a hold rating in a research note released on Tuesday.
CCLP has been the topic of several other research reports. BidaskClub cut CSI Compressco from a buy rating to a hold rating in a research report on Monday, May 14th. Raymond James set a $8.00 price target on CSI Compressco and gave the company a buy rating in a research report on Tuesday, May 8th. Zacks Investment Research cut CSI Compressco from a hold rating to a sell rating in a research report on Wednesday, August 1st. Finally, Stifel Nicolaus restated a hold rating and issued a $7.00 price target (down previously from $8.00) on shares of CSI Compressco in a research report on Tuesday, May 8th. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. CSI Compressco currently has an average rating of Hold and an average target price of $7.00.
- [By Ethan Ryder]
Cypress Energy Partners (NYSE: CELP) and Compressco Partners (NASDAQ:CCLP) are both small-cap oils/energy companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends.
- [By Ethan Ryder]
CSI Compressco (NASDAQ: CCLP) and Basic Energy Services (NYSE:BAS) are both small-cap oils/energy companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, profitability, valuation and dividends.
- [By Max Byerly]
Get a free copy of the Zacks research report on CSI Compressco (CCLP)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 10 Casino Stocks To Buy For 2019: Utah Medical Products, Inc.(UTMD)
Advisors’ Opinion:
- [By Joseph Griffin]
Utah Medical Products (NASDAQ:UTMD) was upgraded by investment analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Monday.
- [By Max Byerly]
Utah Medical Products, Inc. (NASDAQ:UTMD) Director Ernst G. Hoyer sold 1,614 shares of the company’s stock in a transaction that occurred on Wednesday, May 9th. The stock was sold at an average price of $104.41, for a total value of $168,517.74. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
- [By Max Byerly]
Utah Medical Products, Inc. (NASDAQ:UTMD) CEO Kevin L. Cornwell sold 8,080 shares of the firm’s stock in a transaction on Friday, June 15th. The stock was sold at an average price of $107.07, for a total value of $865,125.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Top 10 Casino Stocks To Buy For 2019: Cresud S.A.C.I.F. y A.(CRESY)
Advisors’ Opinion:
- [By Joseph Griffin]
Itau Unibanco Holding S.A. grew its stake in Cresud S.A.C.I.F. y A. (NASDAQ:CRESY) by 68.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 74,266 shares of the company’s stock after purchasing an additional 30,257 shares during the period. Itau Unibanco Holding S.A.’s holdings in Cresud S.A.C.I.F. y A. were worth $1,101,000 as of its most recent filing with the Securities and Exchange Commission.
- [By Stephan Byrd]
News coverage about Cresud S.A.C.I.F. y A. (NASDAQ:CRESY) has trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cresud S.A.C.I.F. y A. earned a daily sentiment score of 0.18 on Accern’s scale. Accern also assigned news stories about the company an impact score of 47.6414670877177 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
- [By Shane Hupp]
Cresud S.A.C.I.F. y A. (NASDAQ:CRESY) saw a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 294,367 shares, a decline of 44.8% from the April 30th total of 533,376 shares. Based on an average daily volume of 179,726 shares, the days-to-cover ratio is presently 1.6 days.